Should we be clinically assessing antibody responses to covid vaccines in immunocompromised people?

MLA

Willicombe, Michelle, et al. “Should We Be Clinically Assessing Antibody Responses to Covid Vaccines in Immunocompromised People?” BMJ (Clinical Research Ed.), vol. 377, Apr. 2022, p. o966. EBSCOhost, https://doi.org/10.1136/bmj.o966.

APA

Willicombe, M., Scanlon, M., Loud, F., & Lightstone, L. (2022). Should we be clinically assessing antibody responses to covid vaccines in immunocompromised people? BMJ (Clinical Research Ed.), 377, o966. https://doi.org/10.1136/bmj.o966

Chicago

Willicombe, Michelle, Miranda Scanlon, Fiona Loud, and Liz Lightstone. 2022. “Should We Be Clinically Assessing Antibody Responses to Covid Vaccines in Immunocompromised People?” BMJ (Clinical Research Ed.) 377 (April): o966. doi:10.1136/bmj.o966.